Concepedia

Andreas Clemens

AC

73

Publications

4.3K

Citations

35

H-Index

1974

Active since

Affiliations

Boehringer Ingelheim (Germany)(Current)

Novartis (Switzerland)

University of Freiburg

Heidelberg University

Johannes Gutenberg University Mainz

Andreas Clemens is an author at Boehringer Ingelheim (Germany) specializing in medicine, cardiovascular disease, and pharmacotherapy.

ORCID

Top concepts

Publications per year

1974–2023

73

Publications

73

Risks of stroke and mortality associated with suboptimal anticoagulation in atrial fibrillation patients

Arlene M. Gallagher, Efrosini Setakis, Jonathan Plumb et al. · Thrombosis and Haemostasis · 2011 · 348 citations

Warfarin treatment in patients with atrial fibrillation: Observing outcomes associated with varying levels of INR control

Christopher Ll. Morgan, Phil McEwan, Andrzej Tukiendorf et al. · Thrombosis Research · 2008 · 295 citations

, , +11

The Artificial Beta Cell - A Continuous Control of Blood Sugar by External Regulation of Insulin Infusion (Glucose Controlled Insulin Infusion System)

E. F. Pfeiffer, Ch. Thum, Andreas Clemens · Hormone and Metabolic Research · 1974 · 233 citations

, , +12

Prediction of bleeding events in patients with venous thromboembolism on stable anticoagulation treatment

Frederikus A. Klok, Volker Hösel, Andreas Clemens et al. · European Respiratory Journal · 2016 · 224 citations

Effective elimination of dabigatran by haemodialysis

Harm Peters, Andreas Clemens · Thrombosis and Haemostasis · 2013 · 204 citations

Rows per page

1–5 of 73